StrokeNet Thrombectomy Endovascular Platform

Launched by MEDICAL UNIVERSITY OF SOUTH CAROLINA · Mar 1, 2024

Keywords

ClinConnect Summary

The StrokeNet Thrombectomy Endovascular Platform (STEP) trial is studying how to improve treatment for patients experiencing an acute ischemic stroke (AIS), which happens when a blood vessel in the brain is blocked. This trial is specifically looking at patients who have either large or medium vessel occlusions, which means their strokes are caused by blockages in significant blood vessels in the brain. The trial is currently recruiting participants aged 65 and older, but younger adults can also be included if they meet specific criteria.

To be eligible for the trial, participants must have a suspected acute ischemic stroke and show likely signs of a significant blockage in their brain's blood vessels. They should also arrive at the hospital within 24 hours of their last known well time. However, some people may not be able to join the study, such as those with certain medical conditions or those who have had serious allergic reactions to contrast materials used in imaging. Participants in the trial can expect to receive advanced care and treatment options aimed at restoring blood flow to the brain, which is crucial for recovery. This trial aims to better understand and optimize these treatment methods, contributing to improved outcomes for stroke patients.

Gender

ALL

Eligibility criteria

• STEP PLATFORM INCLUSION CRITERIA:
• • 1. Suspected diagnosis acute ischemic stroke
• • 2. Likely causative intracranial large or medium vessel occlusion
• STEP PLATFORM EXCLUSION CRITERIA:
• • 1. Proven contraindication to endovascular thrombectomy
• • 2. Prisoners/incarcerated
• DOMAIN-SPECIFIC ELIGIBILITY CRITERIA:
• • Each domain may have additional eligibility criteria.
• STEP EVT INDICATION EXPANSION DOMAIN INCLUSION CRITERIA:
• 1. Age 18 years or older 2. Pre-stroke modified Rankin Scale score 0-2 3. Presentation to enrolling hospital within 24 hours of last known well/stroke onset 4. Has one of the following presentations:
• 1. LVO patients with mild deficits/low NIHSS (must have both):
• • 1. Mild presenting neurologic deficits - NIHSS 0-5
• • 2. Occlusion of the intracranial Internal Carotid Artery (ICA) or M1 Middle Cerebral Artery (MCA)
• 2. Medium/Distal Vessel Occlusion (must have all 4):
• • 1. Visualized occlusion or perfusion deficit supportive of a cortical branch occlusion (10 cc volume of Tmax \>4s) in one of the following vessels: i) Non-dominant/Co-dominant M2 (defined as serving \< 50% of entire overall MCA territory) ii) M3 iii) M4 iv) A1 v) A2 vi) A3 vii) P1 viii) P2 ix) P3
• • 2. Less than 50% core in the territory supplied by the occluded vessel as evident by hypodensity and loss of grey-white border on NCCT or ADC \<620 mm2/s on diffusion MRI or rCBF\<30% on CTP after 6h of symptom onset.
• • 3. NIHSS \> 4 or NIHSS 2-3 with clearly disabling deficits at presentation to enrolling hospital
• • 4. Able to initiate arterial puncture within 2 hours from qualifying CTA/MRA or CTP/MRP imaging.
• • CT/MR and qualifying CTA/MRA or CTP/MRP should be repeated if more than 120 minutes have elapsed since the imaging and randomization has not been performed.
• STEP EVT INDICATION EXPANSION DOMAIN EXCLUSION CRITERIA:
• • 1. Clinical
• • 1. Presumed septic embolus; suspicion of bacterial endocarditis
• • 2. Seizure at stroke onset or between onset and enrollment
• • 3. Known anaphylactic reaction to contrast material that precludes endovascular reperfusion therapy
• • 4. Intracranial occlusion suspected to be chronic, based on history and/or imaging
• • 5. Intracranial dissection, based on history and/or imaging
• • 6. Cerebral vasculitis, based on history and/or imaging
• • 7. Known pregnancy
• • 8. Known pre-existing medical, neurological or psychiatric disease that would confound the neurological or functional evaluations
• • 9. Known serious, advanced, or terminal illness or life expectancy less than 6 months in the investigator judgment
• • 2. Laboratory
• • a. Known platelet count \<100,000/uL
• • 3. Imaging
• • 1. CT ASPECT score \<6 (MRI ASPECT score \<7)
• • 2. Unfavorable vascular anatomy that limits access to the occluded artery precluding endovascular reperfusion therapy.
• • 3. Acute occlusions in multiple vascular territories (e.g., bilateral anterior circulation, or anterior/posterior circulation)
• • 4. Significant mass effect with midline shift (\>5mm)
• • 5. Evidence of intra-axial tumor (except small meningioma)
• • 6. Evidence of acute intracranial hemorrhage